Buy report from Kotak. Target of 260.
Posts tagged Value Pickr
Buy Unlisted Shares (12-06-2024)
We can’t do anything about it even if it is unethical. Listed companies are better in this respect. In unlisted companies, any investor can decide that the company is not worth its current valuation and cut it’s valuation causing loss to all invested.
Pharmeasy valuation cut was bad for all invested except Dr. Velumani who had secured anti-dilution rights ahead of his investment in the firm. This will ensure he is allotted new shares to compensate for the massive erosion in the current value of his holding in the company.
It is also rare for a company to give these anti-dilution rights. This dilution is another risk in unlisted companies.
Focus Lighting & Fixtures Limited (SME) (12-06-2024)
As you have rightly pointed out, there is clear disconnect between what management claims as their uniqueness vis-à-vis what P&L says and hence what market believes. I have checked with my few interior designer/architect friends and they have not heard of this company, which is bit surprising. If their lights are indeed so unique, world should be running after them or at least should be aware of them.
Secondly if you visit their company website, it is made in WordPress ! It is so poorly designed and many sections like Äbout Us” “Our Clients” and “contact us” do not work. Only investors section seems to be populated. See the link below
https://www.focuslightingandfixtures.com/
A company claiming to be so innovative and wants to attract more customers to itself is having such a poor front end to the world. I am aware that they have separate website for pluslight tech but neither one can visit that website from main company website nor that website shows any connection to main company. Sounds fishy, isn’t it?
In recent concall, I had raised this question to Mr. Sheth about why the company website feels like “work in progress” but he brushed aside my question saying as company is evolving the website would be like this…
Disclosure – Invested but started feeling nervous. May exit in near future
JHS Svendgaard – An Oral Care FMCG Major In Making (12-06-2024)
Recently the company has done allotment of shares worth 30 cr to various entities (including promoter). They are raising fund for plant expansion in Jammu even though the current plant is running at 33% utilization levels. Announcement link –
Buy Unlisted Shares (12-06-2024)
That is where the difference lies. Pharmeasy made a rights offer, which is fair to all investors. Vikram Solar are offering selectively.
Action of Vikram Solar is unethical (though saying it doesn’t help us) even if it is not legally actionable.
Disclaimer: I have investment in Pharmeasy too.
Buy Unlisted Shares (12-06-2024)
There is some guidelines for warrants and preferential allotment in listed entities by SEBI but unlisted companies don’t come under its purview. New investors in unlisted companies can buy at any valuation depending upon their internal assessment and upon aggreement with the promoter. Many promoters sell their stake at lower valuation to renowned investors to gain credibility. There is no legal way to stop a company from selling their share at lower price.
Let me remind everyone that Pharmeasy did a rights issue at 90% discount!!!
Investing Basics – Feel free to ask the most basic questions (12-06-2024)
Any one has Idea about chemicals/resigns used in water treatment/ purification and which companies are pioneer in those chemicals?.
Rajesh’s portfolio (12-06-2024)
Sable was fraud was known, jis investor interactions were maniplulative too. Kore mgt is transparent in interactions, may like to go through two transcripts or video. We have to remain vigilant to see that they walk the path
Nithin’s Portfolio (12-06-2024)
My notes
Not all sectors are free to hide
If you see valuations of capital goods, power, infrastructure, psu, railway’s doesn’t give me any comfort to enter them…
Of course there are certain stocks that might do well but the big question here is
Will FII or DII buy such expensive companies?
They too will think and calculate the risks and upside left for the stock…
Of course if any HNI or DII/FII has bought this stock at a far very cheap price they would tend to average at some correction
But what about those who are waiting on sideline?
From sectors point of view I see
Auto
Chemical
Pharma
Are still normal to cheap level depending on each company.
Defense is a big opportunity however what are in defense
Drone
Anti Drone
Radar
Aerospace
These would do definitely well
NPST – Technology Provider for UPI Tech (12-06-2024)
It looks like an absolute bull market moment:
A debt-free software company trading at a 125 P/E going for a QIP. Don’t know what they are going to do with 240 crore of cash (assuming 1500 as the QIP price). Also, promoters are selling some of their holdings via OFS.
